Hyaluronate nano fabric sheet and preparation method thereof

Through electrospinning technology, ultra-low molecule and medium molecule hyaluronate are mixed to prepare hyaluronate nanofabric sheets with high percutaneous absorption and excellent mechanical properties, solving the existing hyaluronate membrane The problem of complex preparation and low absorption rate has achieved safe and efficient skin applications.

CN118974335AActive Publication Date: 2024-11-15JINWOO BIO
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202380031780.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-06-14
Filing Date
2023-03-23
Publication Date
2024-11-15
Estimated Expiration
2043-03-23

AI Technical Summary

Technical Problem

The existing hyaluronate films are complex in mass production, and have low percutaneous absorption, making them difficult to effectively fit the skin. In addition, toxic organic solvents or alkaline solvents are required for electrospinning preparation, which poses safety risks.

Method used

Using purified water as a solvent, 88.9 to 98.1% by weight of ultra-low molecular hyaluronate with a weight average molecular weight of 5×103 to 5×104Da and 1.9 to 11.1% by weight of 1×105 were electrospinned. Mixed medium molecular hyaluronate with ~1×106Da, prepare a hyaluronate aqueous solution with a viscosity of 1,000-15,000 cPs, and form hyaluronate fibers with a diameter of 0.3-5μm, and prepare a percutaneous absorption rate and mechanical properties. Excellent nanofabric sheet.

Benefits of technology

The percutaneous absorption rate of 77.70 to 86.08% and the tensile strength of 5.32 to 10.91Mpa was achieved, and the risk of using toxic solvents was avoided. It was suitable as a carrier for skin topical agents and ophthalmic drug delivery systems.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118974335A_ABST
    Figure CN118974335A_ABST
Patent Text Reader

Abstract

The present invention relates to a hyaluronate nano-fabric sheet and a method for preparing the same, and more particularly, to a hyaluronate nano-fabric sheet having excellent percutaneous absorption rate and physical properties, and a method for preparing the same. The method for producing a hyaluronate nanofabric sheet according to the present invention is characterized by comprising the steps of: (a) preparing an aqueous hyaluronate solution by mixing and dissolving a hyaluronate having a weight-average molecular weight of 5 * 103-5 * 104 Da and a hyaluronate having a weight-average molecular weight of 1 * 105-1 * 106 Da in water; and (b) electrospinning the aqueous hyaluronate solution. The hyaluronate nanofabric sheet according to the present invention is mainly composed of ultra-low molecular weight hyaluronic acid, has excellent transdermal absorption rate, and also has excellent mechanical properties due to the mixing of a certain amount of medium molecular weight hyaluronic acid. Therefore, the composition can be used as a mask patch for an external skin preparation, a carrier for an ophthalmic or mucosal drug delivery system, and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a hyaluronate nano-fabric sheet and a preparation method thereof, and more specifically, to a hyaluronate nano-fabric sheet with excellent transdermal absorption rate and physical properties and a preparation method thereof. Background Art

[0002] Hyaluronic acid or hyaluronate is evenly distributed in the connective tissue, epithelium and nerve tissue of the human body. As a biocompatible material with multiple physiological activities, it can contain a large amount of water. Due to its excellent viscoelasticity, as its effects on skin regeneration and moisturizing, maintaining elasticity and improving wrinkles have been confirmed, the demand for anti-aging related cosmetics, foods, pharmaceuticals and fillers for medical devices containing it is rapidly increasing.

[0003] Finished products using hyaluronate currently sold on the market are all in liquid form and contain a dilute concentration of hyaluronate, that is, the main component is not hyaluronate but mostly water, so there are limitations in use. Of course, since hyaluronate itself has low safety to microorganisms, when used as a medicine or medical device, it must be prepared in a sterile facility, and when used as a cosmetic, preservatives that pose safety risks must be used.

[0004] Therefore, solidification of hyaluronic acid or hyaluronate into a non-liquid film, fiber, etc. has been studied.

[0005] Korean Patent Publication No. 2019-0138907 discloses a facial mask sheet comprising a hyaluronic acid film, and Korean Patent Publication No. 2019-0106091 discloses a method for preparing a hyaluronate film using a solvent casting or an automatic applicator casting method.

[0006] However, the preparation process of hyaluronate film is somewhat complicated in mass production, and when used as a facial mask, there are problems such as poor adhesion to the skin or low transdermal absorption rate.

[0007] In order to improve the preparation process of such hyaluronate film, Korean registered patent No. 2338355 discloses a method for preparing a wet hyaluronate nonwoven fabric, which can be used as a beauty patch, a wet wound dressing, a tissue adhesion prevention film, etc., and Korean registered patent No. 1224882 discloses a nanofiber sheet made of hyaluronic acid. However, since Korean registered patent No. 2338355 uses a hyaluronate with a molecular weight of 50,000 to 100,000 Da, and Korean registered patent No. 1224882 uses a hyaluronate with a molecular weight of 100,000 to 1,600,000 Daltons (Da), there is a problem of low percutaneous absorption rate.

[0008] Hyaluronic acid or hyaluronate can be divided into ultra-low molecular weight, low molecular weight, medium molecular weight and high molecular weight according to different molecular weights.

[0009] Although medium-molecular and high-molecular hyaluronates have excellent mechanical properties and are easy to form into films, they are difficult to penetrate and absorb into the skin. On the other hand, the lower the molecular weight of hyaluronic acid or hyaluronate, the easier it is to penetrate and absorb into the skin, but due to its low mechanical properties, there is a problem that it is difficult to form a film.

[0010] In addition, in the case of hyaluronate, it is a high molecular polysaccharide containing many hydroxyls in the molecule, and due to the positive charge of the molecule itself, there are many limitations in electrospinning. Therefore, when preparing hyaluronate non-woven fabrics by existing electrospinning, alkaline solvents such as sodium hydroxide or potassium hydroxide are used (Castro, KC, Campos, MGN, & Mei, LHI (2021). International Journal of Biological Macromolecules (International Journal Of Biological Macromolecules), 173, 251-266.), or toxic organic solvents (Ewelina et al. Advances in Polymer Technology) 37.6 (2018): 1929-1940.) are used to prepare hyaluronic acid non-woven fabrics, but toxic organic solvents or salts must be used. In addition, due to concerns that these organic solvents or salts may remain after forming non-woven fabrics, they are limited in actual use.

[0011] Therefore, in order to prepare a hyaluronic acid sheet with excellent mechanical properties for commercialization without adding organic solvents and salts, the present inventors have made efforts to confirm that a hyaluronic acid sheet with a density of 5,000 to 5×10 4 Da ultra-low molecular weight hyaluronic acid is the main component, and 1×10 5 ~1×10 6 After the middle molecular weight hyaluronate of Da is dissolved in water, the hyaluronate nano-textile sheet with excellent transdermal absorption rate and mechanical properties can be prepared by electrostatic spinning, thereby completing the present invention. Summary of the invention

[0012] Technical issues to be solved

[0013] The object of the present invention is to provide a hyaluronate nano-textile sheet having excellent transdermal absorption rate and physical properties.

[0014] Another object of the present invention is to provide a method for preparing a hyaluronate nanofabric sheet having excellent transdermal absorption rate and tensile strength.

[0015] Solutions to the problem

[0016] In order to achieve the above object, the present invention provides a hyaluronate nanofabric sheet, which is made of hyaluronate fibers with a diameter of 0.3 to 5 μm prepared by electrospinning using pure water alone as a solvent.

[0017] In order to achieve the above object, the present invention provides a hyaluronate nano-fabric sheet, the transdermal absorption rate of which is 77.70-86.08% and the tensile strength is 5.32-10.91 Mpa.

[0018] In the present invention, it is characterized in that the hyaluronate is composed of 88.9 to 98.1% by weight of a hyaluronate having a weight average molecular weight of 5×10 3 ~5×10 4 Da of hyaluronate and 1.9 to 11.1% by weight of the weight average molecular weight of 1 × 10 5 ~1×10 6 Da of hyaluronate composition.

[0019] The present invention is characterized in that the hyaluronate sheet is used as a carrier for a mask patch for external skin preparations, or a drug delivery system for ophthalmology or mucosal application.

[0020] The present invention also provides a method for preparing a hyaluronate nanofabric sheet, the method comprising the following steps: (a) preparing a hyaluronate nanofabric sheet having a weight average molecular weight of 5×10 3 ~5×10 4 Da hyaluronate and a weight average molecular weight of 1×10 5 ~1×10 6 Da of hyaluronate are mixed and dissolved in water to prepare an aqueous hyaluronate solution; and (b) electrospinning the aqueous hyaluronate solution.

[0021] In the present invention, the viscosity of the hyaluronate aqueous solution is 1,000 to 15,000 cPs.

[0022] Effects of the Invention

[0023] The hyaluronate nano-textile sheet of the present invention has ultra-low molecular weight hyaluronic acid as a main component, and not only has an excellent transdermal absorption rate, but also has excellent mechanical properties due to the mixing of a certain amount of medium molecular weight hyaluronic acid. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1: is a photo of a hyaluronate nanofabric sheet prepared by an electrospinning method according to an embodiment of the present invention. (A: nanofiber-form sheet, B: dot-form sheet, C: microphotograph of nanofiber-form sheet, D: microphotograph of dot-form sheet)

[0025] Figure 2 This is a penetration experiment photograph of a hyaluronate nanofabric sheet prepared according to an embodiment of the present invention using a fluorescence microscope. DETAILED DESCRIPTION

[0026] Best Mode for Carrying Out the Invention

[0027] In the present invention, "hyaluronate nanofabric sheet" refers to a sheet comprising nano hyaluronate fibers prepared by electrospinning.

[0028] The lower the molecular weight of hyaluronic acid or hyaluronate, the easier it is to penetrate and absorb into the skin. However, there is a problem that it is difficult to prepare a sheet having high physical properties by electrospinning.

[0029] Korean registered patent No. 2338355 uses hyaluronic acid with a molecular weight of 50,000 to 100,000 Da to prepare hyaluronic acid nonwoven fabrics, and Korean registered patent No. 1224882 uses hyaluronic acid with a molecular weight of 100,000 to 1,600,000 Da to prepare hyaluronic acid nanofiber sheets. Since they use high molecular weight hyaluronic acid, alkaline solvents such as sodium hydroxide and potassium hydroxide are used to reduce viscosity. Due to the low transdermal absorption rate, there is a problem that various physiological activities of hyaluronic acid cannot be smoothly transmitted to the skin.

[0030] In the present invention, it is intended to confirm that when 5×10 3 ~5×10 4 Da ultra-low molecular weight hyaluronic acid was added 1×10 5 ~1×10 6 When the medium-molecular hyaluronate is used in an amount of Da, a hyaluronate nanotextile sheet having not only excellent transdermal absorption rate but also excellent mechanical properties with a processability can be uniformly produced in large quantities.

[0031] In the present invention, after ultra-low molecular weight hyaluronate and medium molecular weight hyaluronate are mixed, no alkaline solvent is added, and only purified water is used to dissolve them to prepare a hyaluronate aqueous solution with a viscosity of 1,000 to 15,000 cPs (25° C.), and a hyaluronate nanofabric sheet is prepared by electrospinning.

[0032] As a result, it was confirmed that a large amount of hyaluronate nanowoven fabric sheet can be produced, and the transdermal absorption rate of the produced hyaluronate nanowoven fabric sheet was 77.70 to 86.08%.

[0033] Therefore, in one aspect, the present invention relates to a hyaluronate nanofabric sheet made of hyaluronate fibers having a diameter of 0.3 to 5 μm prepared by electrospinning using pure water alone as a solvent.

[0034] In addition, on the other hand, the present invention relates to a hyaluronate nano-fabric sheet, the transdermal absorption rate of which is 77.70-86.08% and the tensile strength is 5.32-10.91 MPa.

[0035] The hyaluronate constituting the hyaluronate nanofabric sheet is characterized in that 88.9 to 98.1% by weight of the hyaluronate nanofabric sheet has a weight average molecular weight of 5×10 3 ~5×10 4 Da of hyaluronate and 1.9 to 11.1% by weight of the weight average molecular weight of 1 × 10 5 ~1×10 6 Da of hyaluronate composition.

[0036] That is, the hyaluronate nanofabric sheet of the present invention cannot be formed into a sheet having high physical properties by electrospinning only hyaluronic acid having a molecular weight equivalent to ultra-low molecular weight, and therefore hyaluronic acid having a molecular weight equivalent to medium molecular weight is used together to form the skeleton of the sheet.

[0037] In the present invention, the molecular weight of the ultra-low molecular weight hyaluronate is 5×10 3 ~5×10 4 Da, which is equivalent to the molecular weight of the middle molecule hyaluronate, is 1×10 5 ~1×10 6 Da.

[0038] When the molecular weight is 5×10 3 ~5×10 4 When the hyaluronic acid content of Da is less than 88.9 wt %, a sheet cannot be prepared or the transdermal absorption rate is low, and when it exceeds 98.1 wt %, a sheet is formed but there is a problem of reduced physical properties such as tensile strength.

[0039] In the present invention, the hyaluronate is a substance in which a salt is bonded to hyaluronic acid, and examples thereof include sodium hyaluronate, calcium hyaluronate, potassium hyaluronate, etc., but are not limited thereto.

[0040] On the other hand, the present invention relates to a method for preparing a hyaluronate nanofabric sheet, the preparation method comprising the following steps: preparing a hyaluronate nanofabric sheet having a weight average molecular weight of 5×10 3 ~5×10 4 Da hyaluronate and a weight average molecular weight of 1×10 5 ~1×10 6Da of hyaluronate are mixed and dissolved in water to prepare an aqueous hyaluronate solution; and (b) electrospinning the aqueous hyaluronate solution.

[0041] In the present invention, the weight average molecular weight is 5×10 3 ~5×10 4 Da of hyaluronic acid with a weight average molecular weight of 1×10 5 ~1×10 6 The weight ratio of hyaluronic acid in Da is preferably 88.9 to 98.1% by weight: 1.9 to 11.1% by weight.

[0042] In the present invention, the viscosity of the hyaluronic acid solution mixed with ultra-low molecular weight and medium molecular weight hyaluronic acid is preferably 1,000 to 15,000 cPs (25°C) (Brookfield DV2RTVJO, spindle No. 5, rpm 12). The viscosity of the solution can vary depending on the HA molecular weight (Da), HA content and the ratio with the solvent. When the viscosity is less than 1,000 cPs, it is difficult to form a sheet. When it exceeds 15,000 cPs, due to high viscosity, the nozzle is clogged, so there is a concern that electrospinning cannot be carried out smoothly.

[0043] In the present invention, the electrospinning is preferably performed under the conditions of tension (Tension): 30-35 (kV), flow rate (FlowRate): 10-20 (mL / h), and distance (Distance): 10-15 (cm).

[0044] In the present invention, the hyaluronate sheet prepared by electrospinning may be composed of hyaluronate fibers having a diameter of 0.3 μm to 5 μm.

[0045] In the present invention, a solvent is used to dissolve hyaluronate, and purified water is preferably used.

[0046] In addition, in the case of the hyaluronic acid sheet prepared by electrospinning used in the present invention, hyaluronate can be used alone for preparation, but depending on the application field, water-soluble and low molecular weight carriers or excipient components commonly used in the art may also be added, and their types and content ranges are not particularly limited.

[0047] Modes for Carrying Out the Invention

[0048] The present invention is described in more detail below by way of examples. These examples are only used to illustrate the present invention, and it is obvious to those skilled in the art that the scope of the present invention should not be construed as being limited by these examples.

[0049] Example 1: Preparation of hyaluronate nanofabric sheets by electrospinning

[0050] Using an electrospinning apparatus (NE300, Inovenso, Turkey), the tension, flow rate and distance were set as shown in Table 1 below, and spinning was performed by changing the conditions of the hyaluronate molecular weight and the concentration of the aqueous solution.

[0051]

Table 1

[0052]

[0053]

[0054] The viscometer (DV2TRV TJO, Brookfield Engineering Labs Inc., USA) was used to measure the viscosity at 12 rpm, 30 sec, and 25°C. Table 1 shows that the hyaluronate with a molecular weight of 5 kDa to 50 kDa can be prepared into a sheet by electrospinning. It can be seen that depending on the hyaluronate concentration or molecular weight, a sheet in the form of nanofibers with high physical properties can be prepared, and a sheet in the form of a part of dots with weak physical properties can also be prepared ( Figure 1 ).

[0055] Example 2: Preparation of hyaluronate nanofabric sheets by electrospinning

[0056] Using the hyaluronate aqueous solution composition shown in Table 2, electrospinning was performed in the same manner as in Example 1 under the conditions of tension: 30 (kV), flow rate: 10 to 30 (mL / h), and distance: 10 to 15 (cm).

[0057]

Table 2

[0058]

[0059]

[0060] From Table 2, we can see that when 5×10 3 Da, 1×10 4 Da and 5×10 4 When the hyaluronic acid salt with a weight average molecular weight of 5×10 3 ~5×10 4 Da hyaluronate, the content of which is 1.9 to 11.1% by weight, has a weight average molecular weight of 1×10 5 ~1×10 6 When the Da of hyaluronate and the solution viscosity are 1,000 to 15,000 cPs, a hyaluronate nanotextile sheet can be formed.

[0061] Experimental Example 1. Confirmation of the microstructure of hyaluronate nanofabric sheet

[0062] The microstructure of the hyaluronate nanofabric sheets prepared by electrospinning was confirmed using a microscope (CX33RTFS2, Olympus Corporation., Korea). Figure 1 In the case of the hyaluronate nanotextile sheet, nanofibers with high physical properties (Example 2-4) or dot structures with low physical properties (Examples 2-6 and 2-11) can be confirmed depending on the molecular weight and concentration of the hyaluronate.

[0063] Experimental Example 2. Evaluation of percutaneous absorption rate and measurement of tensile strength

[0064] The test for evaluating the percutaneous absorption rate was conducted according to the "Guidelines for Biological Skin Absorption Tests" using a Franz Diffusion Cell (effective area: 0.64 cm 2 The skin penetration test was performed under sink condition using a 100% saturation (100% saturation) ELISA instrument (Logan Instruments, New Jersey, USA).

[0065] Phosphate buffered saline (PBS) with a pH of 7.4 was used in the skin permeation test. The prepared human skin epidermis (1.5 cm × 1.5 cm) was placed on the receptor chamber with the stratum corneum facing upward, the donor chamber was covered and fixed with a clamp, and then the aqueous phase was filled into the Franz diffusion cell and maintained at 32 ± 1 ° C. 100 ml of hyaluronic acid sheet solution was evenly applied to the donor site to perform the permeation experiment. After the permeation experiment was performed, 5 ml of the aqueous phase was collected and analyzed after 1 hour, 3 hours, 6 hours, 9 hours, 12 hours and 24 hours, and new phosphate buffered saline was added.

[0066] In addition, for further qualitative analysis, referring to the methods of Fudala, Rafal et al. and de Belder, Anthony N. et al. (Photobiology B: Biology 104.3 (2011), Carbohydrate Research 44.2 (1975)), fluorescence microscopy was used to confirm that the hyaluronic acid nonwoven fabric (Examples 2-4) penetrated into the skin after 3 hours under the same permeation test conditions ( Figure 2 ).

[0067] When measuring the tensile strength, the tensile strength of the hyaluronate sheet prepared in Example 2 was measured, and the results are shown in Table 3. A sample having a length of 15 cm and a width of 2.5 cm was mounted on a test fixture, and the tensile strength was measured using a universal material testing machine with the crosshead speed set to 2 mm / min.

[0068]

Table 3

[0069]

[0070]

[0071] Although using 5×10 3 Da, 1×10 4 Da or 5×10 4 The percutaneous absorption rate of the hyaluronate nanofabric sheet prepared by the hyaluronate of Da is 87.34-92.81%, which is high, but the tensile strength is measured at 2.14-3.08Mpa, which is not good in physical properties, so there is a problem of sheet damage during processing after punching and packaging. On the other hand, in the case of the hyaluronate nanofabric sheet prepared by mixing ultra-low molecular and medium molecular hyaluronic acid, the percutaneous absorption rate is 77.70-86.08%, and the tensile strength is measured at 5.32-10.91Mpa, which is not only excellent in percutaneous absorption rate, but also excellent in physical properties, and is suitable for use as a mask for skin external preparations, a carrier for ophthalmic or mucosal drug delivery systems, etc.

[0072] In particular, it was confirmed that the lower the molecular weight of the mixed medium-molecular hyaluronate, the higher the transdermal absorption rate, but the lower the tensile strength.

[0073] Above, specific parts of the present invention are described in detail. For those skilled in the art, it is obvious that these specific technologies are only preferred embodiments and the scope of the present invention is not limited thereby. Therefore, the actual scope of the present invention is defined by the claims and their equivalents.

[0074] Industrial Applicability

[0075] Since the hyaluronate nanotextile sheet of the present invention also has excellent mechanical properties, it can be used in various applications such as a mask for external skin preparations, a carrier for ophthalmic or mucosal drug delivery systems, and the like.

Claims

1. A hyaluronate nanofabric sheet, wherein: The hyaluronate nanofabric sheet is made of hyaluronate fibers with a diameter of 0.3 to 5 μm prepared by electrostatic spinning using pure water alone as a solvent.

2. A hyaluronate nanofabric sheet, wherein: The transdermal absorption rate of the hyaluronate nano-fabric sheet is 77.70-86.08%, and the tensile strength is 5.32-10.91 Mpa.

3. The hyaluronate nanofabric sheet according to claim 2, characterized in that: The hyaluronate is composed of 88.9 to 98.1% by weight of a weight average molecular weight of 5×10 3 ~5×10 4 Da of hyaluronate and 1.9 to 11.1% by weight of the weight average molecular weight of 1 × 10 5 ~1×10 6 Da of hyaluronate composition.

4. The hyaluronate nanofabric sheet according to claim 2, characterized in that: The hyaluronate sheet is used as a mask for external skin preparations, or as a carrier for ophthalmic or mucosal drug delivery systems.

5. A method for preparing a hyaluronate nanofabric sheet, wherein: The preparation method comprises the following steps: (a) The weight average molecular weight is 5×10 3 ~5×10 4 Da hyaluronate and a weight average molecular weight of 1×10 5 ~1×10 6 Da of hyaluronate are mixed and dissolved in water to prepare a hyaluronate aqueous solution; and (b) Electrospinning of hyaluronate aqueous solution.

6. The method for preparing the hyaluronate nanofabric sheet according to claim 5, characterized in that: The weight average molecular weight is 5×10 3 ~5×10 4 Da hyaluronate with a weight average molecular weight of 1×10 5 ~1×10 6 The weight ratio of the hyaluronate of Da is 88.9 to 98.1 wt %:1.9 to 11.1 wt %.

7. The method for preparing the hyaluronate nanofabric sheet according to claim 5, characterized in that: The viscosity of the hyaluronate aqueous solution is 1,000 to 15,000 cPs.

Citation Information

Patent Citations

  • Novel low molecular weight hyaluronic acid and / or salt thereof, and cosmetic preparation, pharmaceutical composition, and food composition each using same

    CN101415731A

  • Hyaluronic acid anti-aging composition and preparation method and application thereof

    CN106137786A

  • Preparation method of supermolecule nanofiber based on modified hyaluronic acid

    CN111607844A

  • Novel hyaluronic acid facial mask, and preparation method and application method thereof

    CN111759749A

  • Nanofibrous sheet comprising hyaluronic acid and nanofibrous scaffold for enhanced tissue regeneration using the same

    KR1020110116616A